<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00909714</url>
  </required_header>
  <id_info>
    <org_study_id>NETS Trial</org_study_id>
    <nct_id>NCT00909714</nct_id>
  </id_info>
  <brief_title>Neuroregeneration Enhanced by Transcranial Direct Current Stimulation (TDCS) in Stroke</brief_title>
  <acronym>NETS</acronym>
  <official_title>Neuroregeneration Enhanced by TDCS in Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Testing the hypothesis that non-invasive brain stimulation by transcranial direct current
      stimulation (tDCS) combined with functional training in the subacute phase of first-ever
      stroke will enhance functional regeneration compared with a Placebo intervention.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Stroke is the leading cause of long-term disability, which significantly impairs the economic
      and social life of patients and society. Every year 200 000 to 250 000 patients suffer a
      stroke in Germany. Only a small number of the stroke survivors recover to a degree that
      allows them to return into their professional and private life. Despite significant efforts
      to develop novel and efficient treatment strategies the level of functional regeneration is
      still not satisfying. Thus, the development of innovative and effective treatment strategies
      will have a major impact for the patients' life, the society and the public health system.

      Within the proposed project an innovative, non-invasive and cost effective interventional
      strategy, based on the combination of a specific rehabilitative training and brain
      stimulation by transcranial direct current stimulation (tDCS), will be used to enhance
      functional regeneration in stroke patients. The intervention will be applied in an early
      stage in which plasticity, cortical reorganization and functional improvement is most
      pronounced. We hypothesize that the combination of anodal tDCS delivered to the motor cortex
      of the affected hemisphere combined with training over a period of two weeks in the subacute
      stage after stroke will significantly enhance cortical plasticity, functional regeneration
      and long-term outcome determined by clinical and functional outcome measures compared with
      Placebo stimulation.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>July 2009</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Upper Extremity Fugl-Meyer-Assessment (UEFMA)</measure>
    <time_frame>1-7 days after the end of the intervention</time_frame>
    <description>standardized test of upper extremity function</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Upper Extremity Fugl-Meyer-Assessment (UEFMA)</measure>
    <time_frame>30±10 days after the intervention</time_frame>
    <description>standardized test of upper extremity function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Upper Extremity Fugl-Meyer-Assessment (UEFMA)</measure>
    <time_frame>90±20 days after the intervention</time_frame>
    <description>standardized test of upper extremity function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Upper Extremity Fugl-Meyer-Assessment (UEFMA) | Long-term outcome</measure>
    <time_frame>12±1 months after the intervention</time_frame>
    <description>standardized test of upper extremity function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Action Research Arm Test (ARAT)</measure>
    <time_frame>1-7 days after the end of the intervention</time_frame>
    <description>standardized tests of upper extremity function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Action Research Arm Test (ARAT)</measure>
    <time_frame>30±10 days after the intervention</time_frame>
    <description>standardized tests of upper extremity function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Action Research Arm Test (ARAT)</measure>
    <time_frame>90±20 days after the intervention</time_frame>
    <description>standardized tests of upper extremity function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Action Research Arm Test (ARAT) | Long-term outcome</measure>
    <time_frame>12±1 months after the intervention</time_frame>
    <description>standardized tests of upper extremity function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nine Hole Peg Test (NHPT)</measure>
    <time_frame>1-7 days after the end of the intervention</time_frame>
    <description>standardized test to assess fine motor skills</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nine Hole Peg Test (NHPT)</measure>
    <time_frame>30±10 days after the intervention</time_frame>
    <description>standardized test to assess fine motor skills</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nine Hole Peg Test (NHPT)</measure>
    <time_frame>90±20 days after the intervention</time_frame>
    <description>standardized test to assess fine motor skills</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nine Hole Peg Test (NHPT) | Long-term outcome</measure>
    <time_frame>12±1 months after the intervention</time_frame>
    <description>standardized test to assess fine motor skills</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke Impact Scale (SIS)</measure>
    <time_frame>1-7 days after the end of the intervention</time_frame>
    <description>questionnaire is to evaluate how stroke has impacted health and life of patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke Impact Scale (SIS)</measure>
    <time_frame>30±10 days after the intervention</time_frame>
    <description>questionnaire is to evaluate how stroke has impacted health and life of patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke Impact Scale (SIS)</measure>
    <time_frame>90±20 days after the intervention</time_frame>
    <description>questionnaire is to evaluate how stroke has impacted health and life of patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke Impact Scale (SIS) | Long-term outcome</measure>
    <time_frame>12±1 months after the intervention</time_frame>
    <description>questionnaire is to evaluate how stroke has impacted health and life of patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Box-and-Block Test</measure>
    <time_frame>1-7 days after the end of the intervention</time_frame>
    <description>standardized test to assess fine motor skills</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Box-and-Block Test</measure>
    <time_frame>30±10 days after the intervention</time_frame>
    <description>standardized test to assess fine motor skills</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Box-and-Block Test</measure>
    <time_frame>90±20 days after the intervention</time_frame>
    <description>standardized test to assess fine motor skills</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Box-and-Block Test</measure>
    <time_frame>12±1 months after the intervention</time_frame>
    <description>standardized test to assess fine motor skills</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Grip Force</measure>
    <time_frame>1-7 days after the end of the intervention</time_frame>
    <description>dynamometer-based test to assess grip strength</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Grip Force</measure>
    <time_frame>30±10 days after the intervention</time_frame>
    <description>dynamometer-based test to assess grip strength</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Grip Force</measure>
    <time_frame>90±20 days after the intervention</time_frame>
    <description>dynamometer-based test to assess grip strength</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Grip Force</measure>
    <time_frame>12±1 months after the intervention</time_frame>
    <description>dynamometer-based test to assess grip strength</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Anodal tDCS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Direct Current (DC)-Stimulator to apply tDCS + Training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham tDCS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Direct Current (DC)-Stimulator to apply Sham tDCS (Placebo) + Training</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DC-Stimulator to apply tDCS</intervention_name>
    <description>Anodal tDCS (20 minutes) stimulation will be applied once a day in combination with standardized upper extremity rehabilitative training</description>
    <arm_group_label>Anodal tDCS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DC-Stimulator to apply Sham tDCS</intervention_name>
    <description>Sham stimulation will be applied once a day in combination with standardized upper extremity rehabilitative training</description>
    <arm_group_label>Sham tDCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subacute stroke patients (5-45 days after stroke) with thromboembolic non-hemorrhagic
             subcortical or cortical, first clinically overt stroke will be included. Moderate to
             moderately severe upper-extremity hemiparesis, defined as an Upper Extremity
             Fugl-Meyer score (UEFMA) between 20 and 58 (inclusive).

        Exclusion Criteria:

          -  pre-existing large lesions (&gt; 1.5 cm maximum diameter) in a brain area that belongs to
             the anatomically established sensorimotor/premotor system

          -  progressive stroke

          -  completely lesioned hand knob area of M1 affected if no motor evoked potentials (MEPs)
             elicited by transcranial magnetic stimulation (TMS) are present

          -  bilateral motor impairment

          -  florid alcohol and/or drug abuse

          -  florid severe psychiatric illness (e.g. schizophrenia)

          -  severe language disturbances that prevents the patient to give informed consent or
             inhibit adequate scoring because of insufficient understanding of scoring
             introductions

          -  tumor diseases with a life expectancy less than one year

          -  increased intracranial pressure

          -  polyneuropathy and/or ischemic peripheral disease if the sensorimotor functions of the
             upper extremities are affected clinically relevant

          -  severe cognitive deficits (MMSE ≤ 23)

          -  pregnancy

          -  contraindication for MRI or TMS
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Gerloff, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neurology, University Medical Center Hamburg-Eppendorf</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Neurologische Universitätsklinik Wien</name>
      <address>
        <city>Wien</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik Kipfenberg</name>
      <address>
        <city>Kipfenberg</city>
        <state>Bayern</state>
        <zip>85110</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brandenburgklinik Berlin-Brandenburg</name>
      <address>
        <city>Bernau bei Berlin</city>
        <state>Berlin</state>
        <zip>16321</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Neurologie Moritzklinik</name>
      <address>
        <city>Bad Klosterlausnitz</city>
        <state>Thüringen</state>
        <zip>07639</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Neurologische Klinik Bad Aibling</name>
      <address>
        <city>Bad Aibling</city>
        <zip>83043</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Neurologisches Zentrum Segeberger Kliniken</name>
      <address>
        <city>Bad Segeberg</city>
        <zip>23795</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NRZ Leipzig</name>
      <address>
        <city>Bennewitz</city>
        <zip>04828</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MEDIAN Klinik Berlin-Kladow</name>
      <address>
        <city>Berlin</city>
        <zip>14089</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Center Hamburg Eppendorf (UKE)</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Center Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fondazione Santa Lucia</name>
      <address>
        <city>Rome</city>
        <zip>00179</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Germany</country>
    <country>Italy</country>
  </location_countries>
  <removed_countries>
    <country>France</country>
    <country>Switzerland</country>
  </removed_countries>
  <reference>
    <citation>Bönstrup M, Schulz R, Schön G, Cheng B, Feldheim J, Thomalla G, Gerloff C. Parietofrontal network upregulation after motor stroke. Neuroimage Clin. 2018 Mar 7;18:720-729. doi: 10.1016/j.nicl.2018.03.006. eCollection 2018.</citation>
    <PMID>29876261</PMID>
  </reference>
  <reference>
    <citation>Buch ER, Santarnecchi E, Antal A, Born J, Celnik PA, Classen J, Gerloff C, Hallett M, Hummel FC, Nitsche MA, Pascual-Leone A, Paulus WJ, Reis J, Robertson EM, Rothwell JC, Sandrini M, Schambra HM, Wassermann EM, Ziemann U, Cohen LG. Effects of tDCS on motor learning and memory formation: A consensus and critical position paper. Clin Neurophysiol. 2017 Apr;128(4):589-603. doi: 10.1016/j.clinph.2017.01.004. Epub 2017 Jan 29. Review.</citation>
    <PMID>28231477</PMID>
  </reference>
  <reference>
    <citation>Bikson M, Grossman P, Thomas C, Zannou AL, Jiang J, Adnan T, Mourdoukoutas AP, Kronberg G, Truong D, Boggio P, Brunoni AR, Charvet L, Fregni F, Fritsch B, Gillick B, Hamilton RH, Hampstead BM, Jankord R, Kirton A, Knotkova H, Liebetanz D, Liu A, Loo C, Nitsche MA, Reis J, Richardson JD, Rotenberg A, Turkeltaub PE, Woods AJ. Safety of Transcranial Direct Current Stimulation: Evidence Based Update 2016. Brain Stimul. 2016 Sep-Oct;9(5):641-661. doi: 10.1016/j.brs.2016.06.004. Epub 2016 Jun 15. Review.</citation>
    <PMID>27372845</PMID>
  </reference>
  <reference>
    <citation>Wessel MJ, Zimerman M, Timmermann JE, Heise KF, Gerloff C, Hummel FC. Enhancing Consolidation of a New Temporal Motor Skill by Cerebellar Noninvasive Stimulation. Cereb Cortex. 2016 Apr;26(4):1660-7. doi: 10.1093/cercor/bhu335. Epub 2015 Jan 20.</citation>
    <PMID>25604611</PMID>
  </reference>
  <reference>
    <citation>Pisegna JM, Kaneoka A, Pearson WG Jr, Kumar S, Langmore SE. Effects of non-invasive brain stimulation on post-stroke dysphagia: A systematic review and meta-analysis of randomized controlled trials. Clin Neurophysiol. 2016 Jan;127(1):956-968. doi: 10.1016/j.clinph.2015.04.069. Epub 2015 May 9. Review.</citation>
    <PMID>26070517</PMID>
  </reference>
  <reference>
    <citation>Bönstrup M, Krawinkel L, Schulz R, Cheng B, Feldheim J, Thomalla G, Cohen LG, Gerloff C. Low-Frequency Brain Oscillations Track Motor Recovery in Human Stroke. Ann Neurol. 2019 Dec;86(6):853-865. doi: 10.1002/ana.25615. Epub 2019 Oct 30.</citation>
    <PMID>31604371</PMID>
  </reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>May 12, 2009</study_first_submitted>
  <study_first_submitted_qc>May 27, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 28, 2009</study_first_posted>
  <last_update_submitted>February 22, 2020</last_update_submitted>
  <last_update_submitted_qc>February 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>stroke</keyword>
  <keyword>non-invasive cortical stimulation</keyword>
  <keyword>motor recovery</keyword>
  <keyword>cortical plasticity</keyword>
  <keyword>TDCS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data sharing is planned after main publication of results.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>Within 24 months after main publication.</ipd_time_frame>
    <ipd_access_criteria>Personal login into UKE data repository.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

